Ibotta shares rose 28.8% on Tuesday to close at $64.51, a move 5.6 times the stock's typical daily range of 5.2% over the past year. The S&P 500 gained 0.4% that session and other covered companies in its industry rose a median 0.3%, making the move company-specific. The most plausible catalyst was third-quarter revenue and adjusted EBITDA that both cleared the upper end of Ibotta's own guidance range, while the fourth-quarter revenue guidance midpoint came in 3% above the analysts' average estimate. A report described non-GAAP earnings per share of $0.62 as 40.4% above consensus, framing the beat as broad across the income statement.
The operating margin of −3.5% is below every past reading in the company's own record, which ran from −2.6% to 21.1%
Capital spending is consuming a growing share of the cash Ibotta generates, and the figures connect directly. Capital expenditure rose 210.2% over the year while operating cash flow fell 13.1%, a combination that pulled free cash flow down to $74.5 million, a decline of 26.4% year over year, and left the free-cash-flow margin at 21.7%, 5.8 percentage points below the year-earlier level.
Profitability has also slipped below its own history even as the top-line decline eases. The operating margin of −3.5% sits below every past reading in the company's own record, which ranges from −2.6% to 21.1%, and is down 12.2 percentage points from a year earlier. Revenue of $343.2 million over the twelve months to Q2 2026 fell 6.6% on the prior year, though the rate of decline narrowed by 1.3 percentage points from the quarter before.
Working against this compression is the shrinking share count. The average diluted share count fell 11.0% over the year, so each remaining share carries a larger claim on whatever profit the company generates.
The share price of $64.51 is above our model's value of $39.00 a share
Our model values Ibotta at $39.00 per share, below the $64.51 close, meaning the market is pricing in more than the company's recent record supports in our model. That gap traces largely to growth assumptions: in our model, growth 5 percentage points lower would lower the value by 22.5%, while growth 5 percentage points higher would raise it by 29.6%.
What Ibotta's next report has to show
The next earnings release will show whether the revenue decline is reversing and whether the operating margin can return to positive territory. The trend in capital spending relative to operating cash flow will determine whether free cash flow continues to compress or stabilizes.